Independent Medical Review

The number nobody wants to lead with

In 2025, Independent Medical Review issued 152,351 determinations in California workers' compensation cases. It upheld the insurance company's denial 89.8% of the time.

That is not an unusual year. Across the last decade the overturn rate has never risen above 12.7% and never fallen below 7.2%. In 2,082,085 applications between 2016 and 2025, IMR sided with the payer roughly nine times out of ten, every year, without exception.

We lead with that because you should know the terrain before you walk it — and because the odds are not the same for every kind of treatment, which is the useful part.

None of this means you should skip IMR. You must file it, both because it is your only route to challenge medical necessity and because failing to file forfeits the issue. But it does mean the real leverage in a denied-treatment case is usually somewhere else: in whether the utilization review that produced the denial was procedurally valid.

What IMR is

When utilization review modifies, delays, or denies your treatment, California does not send the medical dispute to a judge. It sends it to an independent physician reviewer through an organization under contract to the state — Maximus — who reads the file and decides whether the treatment is medically necessary under the MTUS.

The reviewer never examines you. The reviewer's identity is confidential by statute (Labor Code § 4610.6(f)). The decision is binding on all parties, and no judge, no Appeals Board, and no appellate court may substitute a contrary medical-necessity determination.

This structure was upheld against constitutional challenge in Stevens v. WCAB (2015) 241 Cal.App.4th 1074, and against a separation-of-powers challenge in Ramirez v. WCAB (2017) 10 Cal.App.5th 205.

Every IMR deadline

Two of these deserve emphasis.

The 10-day drug window. Since April 1, 2026 the revised DWC Form IMR carries checkboxes flagging whether the 10-day or 30-day deadline applies, plus a mailing-date field. Before that there was nothing on the form to warn you. In 2025, untimely filings rose 5.4%.

Section 4610.5(h)(3) is the most valuable defensive provision in this area. The claims administrator must enclose a one-page IMR application form and an addressed envelope with the denial. If it did not, "the time limitations … shall not begin to run until the employer provides the required notice." That is a complete answer to an untimeliness dismissal. As of April 2026 the failure also carries a $2,000 penalty under 8 CCR § 9792.12(d).

You are allowed to submit your own material. Most workers do not, and it is free. The reviewer decides on a paper record; adding your physician's rebuttal, current imaging, functional findings, and a record of failed conservative care is the only influence you have on the outcome.

Your odds, by treatment type

From the DWC's 2026 IMR Report analyzing 2025 data — 266,756 disputed treatment requests:

Within pharmaceuticals the spread is wider still. Antidepressants are overturned 24.1% of the time — the best-performing drug class by a distance. Muscle relaxants are overturned 1.4%. Opioids, 6.8%. Topical analgesics, 6.0%. NSAIDs, 18.9%.

Two observations worth having.

Spinal injections were added to the mandatory prospective-review list effective April 1, 2026 — a category in which the reviewer sustains the denial 93.3% of the time. More injection requests will now route through UR, and the historical odds at IMR on those requests are poor.

Rehabilitation and pharmaceuticals together are 53.5% of all disputes and both sit near a 9% overturn rate. If your denial is for physical therapy or medication, plan accordingly — which usually means putting the effort into the quality of the resubmission and into checking UR timeliness, rather than into the IMR filing alone.

Who is deciding

85% of 2025 cases were handled by California-licensed reviewers. 77% of decisions came from board-certified specialists in occupational medicine, orthopedic surgery, pain medicine, or physical medicine and rehabilitation.

Occupational medicine physicians decide more than four of every ten California IMRs. Their identities are confidential.

Turnaround is fast and the deadlines are met: average 6–7 days from receipt of complete records to determination, and 99.99% of standard cases issued within the 30-day statutory deadline — only 13 cases statewide exceeded it. Whatever criticisms IMR attracts, being slow is not one of them.

Appealing an IMR determination

You may appeal to the WCAB within 30 days, by verified appeal. The determination is presumed correct and may be set aside only on clear and convincing evidence of one of five grounds (LC § 4610.6(h)):

1. The Administrative Director acted without or in excess of their powers.
2. The determination was procured by fraud.
3. The reviewer had a material conflict of interest violating § 139.5.
4. The determination resulted from bias on the basis of race, national origin, ethnic group identification, religion, age, sex, sexual orientation, color, or disability.
5. The determination resulted from a plainly erroneous express or implied finding of fact, where the mistake is a matter of ordinary knowledge based on the information submitted — and not a matter subject to expert opinion.

Now the part that is rarely said plainly.

Grounds 2, 3, and 4 are close to dead letters. The reviewer's identity is confidential by statute. Proving fraud, a material conflict, or protected-characteristic bias against a person whose name you do not know is, in practice, not achievable.

Ground 1 is narrower than it reads. Ramirez held that an IMR determination cannot be attacked for "acting in excess of powers" merely because the reviewer misapplied the MTUS: "Whether the utilization reviewer correctly followed the medical treatment utilization schedule is a question directly related to medical necessity, and is reviewable only by independent medical review."

Ground 5 is the only realistic path, and it is genuinely available — but it must be pleaded precisely. The classic example comes from Stevens: a denial premised on the patient's weight, where the record shows a different weight. In Gonzalez-Ornelas v. County of Riverside (WCAB panel, 2016), a determination was set aside where the reviewer asserted documentation was missing that was in fact in the record — an error requiring only ordinary knowledge to see.

Medina v. Ajob Staffing (WCAB panel, April 6, 2026) shows the failure mode. The appeal lost because the applicant did not identify which specific records contradicted which specific factual finding. The drafting lesson: quote the reviewer's exact assertion, cite the exact page that contradicts it, and show the contradiction is visible to a lay reader. A general argument that the reviewer got the medicine wrong is a guaranteed loss — by the text of the ground itself, that is expert opinion and therefore excluded.

And then the sting. Under LC § 4610.6(i), if you win, the dispute is remanded for a second IMR by a different review organization — or a different reviewer at the same one. A successful appeal buys you another IMR. It does not buy you treatment.

That is why IMR is, for practical purposes, final.

Where the real leverage is

If the medical question is effectively unappealable, the procedural question is not.

Under Dubon II (WCAB en banc, 2014), a UR decision that is untimely is invalid — and when UR is invalid, the medical necessity dispute goes to a workers' compensation judge, not to IMR. Stevens left that intact. Timeliness is a legal question the Board still decides.

Giron v. KDF Forestry (WCAB panel, April 6, 2026) is the live example. RFA received September 4, 2025; decision due September 11. The employer made phone calls to the treating physician and treated the deadline as extended to fourteen days. The panel reversed the judge: phone calls "did not automatically extend the deadline to 14 days under current law," and there was no written notice of missing information under § 4610(j)(2). UR invalid, medical necessity to the Board.

So the order of operations in a denied-treatment case is:

1. File the IMR application — always, and on time. It costs nothing and failing to file forfeits the issue.
2. Have the UR denial checked for timeliness and procedural defect — this is where cases are actually won.
3. Submit your own supporting documents to IMR — you are entitled to, and almost nobody does.
4. Work with your treating physician on the resubmission — MTUS cited, guideline variance explained, evidence attached, and a documented material change if the twelve-month rule is in play.

Is the system fair?

We will not pretend to neutrality: we represent injured workers, and we think a system in which nine of ten denials are upheld by an anonymous reviewer who never examines the patient, with no meaningful appeal on the merits, is difficult to defend as a matter of design.

But the honest picture is contested, and you should have it.

The payer side points to a real finding: research by the California Workers' Compensation Institute has found that in the twelve months ending March 2025, the top 1% of requesting physicians — 81 doctors — generated 42.2% of all disputed service requests, with the top ten alone accounting for 10.9%. Seven of those top ten repeated from the prior year. Their reading is that a small group of outlier prescribers drives the volume, and IMR is doing what it was built to do. (CWCI is insurer-funded; we cite it because the finding is real, not because the framing is neutral.)

The applicant side reads the same number differently: a small group of physicians still willing to fight for care that most doctors have stopped requesting, because the odds are nine to one against and the paperwork is unpaid.

Both readings fit the data. What is not in dispute is that the overturn rate has moved within a narrow band for a decade, that the reviewers are anonymous, and that winning an appeal gets you a second review rather than a treatment authorization.

Frequently asked questions